We are live on
!
Find out more
Walleye Capital Portfolio holdings
AUM
$24B
1-Year Est. Return
37.67%
This Fund
S&P 500
This Quarter
Est. Return
+4.23%
1 Year Est. Return
+37.67%
3 Year Est. Return
+98.01%
5 Year Est. Return
+160%
10 Year Est. Return
–
AUM
$910M
AUM Growth
+$303M
(+50%)
Cap. Flow
+$298M
Cap. Flow
% of AUM
32.79%
Top 10 Holdings %
Top 10 Hldgs %
6.34%
Holding
2,256
New
789
Increased
455
Reduced
377
Closed
581
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GXGXU
GX Acquisiton Corp. Unit
GXGXU
|
+$2.63M |
| 2 |
LCAHU
Landcadia Holdings II, Inc. Unit
LCAHU
|
+$2.3M |
| 3 |
HYACU
Haymaker Acquisition Corp. II Unit
HYACU
|
+$1.62M |
| 4 |
GIX.U
GigCapital2, Inc.
GIX.U
|
+$1.35M |
| 5 |
Sarepta Therapeutics
SRPT
|
+$1.35M |
Top Sells
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 1.76% |
| 2 | Consumer Discretionary | 1.21% |
| 3 | Technology | 1% |
| 4 | Financials | 0.87% |
| 5 | Industrials | 0.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
CALL
International Flavors & Fragrances
IFF
$19.4B
| $290K | 0.03% |
+2,000
| New | +$278K |
|
752
PUT
Vulcan Materials
VMC
$36.3B
| $288K | 0.03% |
2,100
+1,700
| +425% | +$217K |
|
753
Abeona Therapeutics
ABEO
$345M
| $287K | 0.03% |
+2,400
| New | +$402K |
|
754
CALL
Essent Group
ESNT
$6.06B
| $287K | 0.03% |
+6,100
| New | +$287K |
|
755
PUT
Euronet Worldwide
EEFT
$3.02B
| $286K | 0.03% |
1,700
-1,800
| -51% | -$275K |
|
756
PUT
Martin Midstream Partners
MMLP
$95.9M
| $286K | 0.03% |
40,100
| – | – |
|
757
World Acceptance Corp
WRLD
$950M
| $286K | 0.03% |
+1,743
| New | +$238K |
|
|
FPRX
758
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $286K | 0.03% |
+47,500
| New | +$454K |
|
759
CALL
Zions Bancorporation
ZION
$10.1B
| $285K | 0.03% |
6,200
-14,800
| -70% | -$685K |
|
760
CALL
Commault Systems
CVLT
$5.89B
| $283K | 0.03% |
+5,700
| New | +$303K |
|
761
CALL
Hewlett Packard
HPE
$63.2B
| $283K | 0.03% |
18,900
+5,500
| +41% | +$83.4K |
|
762
CALL
Pentair
PNR
$10.2B
| $283K | 0.03% |
+7,600
| New | +$288K |
|
763
VEON
VEON
$3.53B
| $283K | 0.03% |
+4,040
| New | +$242K |
|
|
GAP
764
The Gap Inc
GAP
$6.84B
| $283K | 0.03% |
+15,743
| New | +$353K |
|
|
RDUS
765
CALL
DELISTED
Radius Health, Inc.
RDUS
| $283K | 0.03% |
11,600
-10,100
| -47% | -$221K |
|
766
PUT
McKesson
MCK
$98.5B
| $282K | 0.03% |
2,100
-100
| -5% | -$12.5K |
|
767
PUT
Henry Schein
HSIC
$9.74B
| $280K | 0.03% |
4,000
-3,500
| -47% | -$231K |
|
768
PNC Financial Services
PNC
$100B
| $280K | 0.03% |
+2,038
| New | +$269K |
|
|
SNV
769
CALL
DELISTED
Synovus
SNV
| $280K | 0.03% |
8,000
-9,500
| -54% | -$330K |
|
|
CALY
770
CALL
Callaway Golf Company
CALY
$3.26B
| $278K | 0.03% |
16,200
-21,100
| -57% | -$348K |
|
771
CALL
Lattice Semiconductor
LSCC
$17.6B
| $277K | 0.03% |
+19,000
| New | +$253K |
|
772
CALL
Brink's
BCO
$5.02B
| $276K | 0.03% |
+3,400
| New | +$271K |
|
773
JD.com
JD
$40.8B
| $276K | 0.03% |
+9,100
| New | +$262K |
|
774
CALL
Constellation Brands
STZ
$22.2B
| $276K | 0.03% |
1,400
-2,800
| -67% | -$547K |
|
|
775
PUT
Constellation Brands
STZ
$22.2B
| $276K | 0.03% |
1,400
-1,000
| -42% | -$195K |
|
Similar funds
JG
SC
OAG
CS
Walleye Capital's Q2 2019 Portfolio in Review
As of Q2 2019, Walleye Capital held 2,256 positions worth $910M, up 50% from $607M the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
Walleye Capital deployed $298M of net new capital in Q2 2019, opening 789 new positions and adding to 455 existing holdings. Its largest new stake was GX Acquisiton Corp. Unit: 261,600 shares worth $2.63M.
By sector, the portfolio is most concentrated in Healthcare at 1.8% of assets, up from 1.3% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Tortoise Acquisition Corp. Units, each consisting of one share of Class A Common Stock and one-half, an estimated $1.87M trimmed.
- Walleye Capital's largest Q2 2019 buy was GX Acquisiton Corp. Unit: 261,600 shares worth $2.63M.
- Walleye Capital added most to Cronos Group in Q2 2019, an estimated $727K increase.
- Walleye Capital's biggest Q2 2019 reduction was Tortoise Acquisition Corp. Units, each consisting of one share of Class A Common Stock and one-half, cutting an estimated $1.87M.
- Walleye Capital fully exited Pivotal Acquisition Corp. in Q2 2019, selling an estimated $1.27M.
- Walleye Capital's ten largest holdings make up 6.3% of its $910M portfolio in Q2 2019.
- Walleye Capital opened 789 new positions and closed 581 in Q2 2019.
- Walleye Capital's portfolio value rose 50% quarter-over-quarter to $910M.
Based on Walleye Capital's 13F filing for Q2 2019, filed 14 Aug 2019.